31,023 Followers on Owler
OverviewCompetitorsAcquisitionsFundingInvestmentsNews & Insights

AbbVie Acquisitions

AbbVie has acquired 17 companies and its latest acquisition was Apogee Therapeutics, Inc. on Jun 2026

Unlock 14 more acquisitions →
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Apogee Therapeutics, Inc.

Jun 2026

Source »
$10.9B
Apogee is a California-based biotechnology company that researches and develops novel therapeutics for the treatment of infectious and inflammatory diseases.

-

Gilgamesh Pharmaceuticals' Bretisilocin

Aug 2025

Source »
$1.2B
-
Capstan Therapeutics, Inc.

Jun 2025

Source »
$2.1B
Capstan is a California-based biotechnology company that researches and develops novel medicines for the treatment of cancer, fibrosis, and inflammatory diseases.
Nimble Therapeutics, Inc

Dec 2024

Source »
$200M
Nimble Therapeutics is a biotechnology company that commercializes proprietary chemical synthesis technology for drug discovery and development.
Aliada Therapeutics, Inc.

Oct 2024

Source »
$1.4B
-

Frequently Asked Questions about AbbVie

  1. What companies did AbbVie acquire?

    Companies acquired by AbbVie include Apogee, and Capstan

  2. How many acquisitions does AbbVie have?

    AbbVie has acquired 17 companies including Apogee, and Capstan.

  1. How many acquisitions did AbbVie make in 2026?

    In 2026 AbbVie acquired 1 companies including Apogee.